This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
8/28/2024
Thank you. Thank you.
Good afternoon, ladies and gentlemen, and welcome to the Analysis Scientific Q2 2024 conference call. At this time, all lines are in listen-only mode. Following the presentation, we will conduct a question and answer session. If at any time during this call you require immediate assistance, please press star zero for the operator. This call is being recorded on Wednesday, August 28, 2024. I would now like to turn the conference over to Mr. Matthew Selinger, Investor Relations. Please go ahead.
Thank you, Operator, and welcome everyone to the Analysis Scientific's second quarter 2024 conference call. Before we begin, I would like to remind everyone that our remarks and responses to your questions today will contain forward-looking statements that are based on the current expectations of management. These assumptions involve inherent risks and uncertainties, that could cause actual results to differ materially from our responses. Certain material factors and assumptions were considered and applied in the making of the forward-looking statements. These risk factors are included in our filings for the year ended December 31st, 2023. Forward-looking statements on this call may include but are not limited to statements and comments with respect to future growth of the company's business, the ability to graduate to a senior exchange, the company's acquisition strategy, the ability to develop future products, and the possible associated results. The company's actual performance and financial results in the future could differ materially from any estimates or projections of future performance implied by the forward-looking statements. The forward-looking statements made on this call speak only as of today, and Analysis Scientific assumes no obligation to update any such forward-looking information as a result of new information, future events, or otherwise, except as expressly required by applicable law. For additional information, I do encourage everyone to review our public filings and press releases, which are posted on the CDAR filing system, which is at www.cdarplus.ca. So on the call with me today are Analysis founder and CEO, Mr. Sean Krakuski, and Analysis CFO, Mr. Randall McRae. So at this point in the call, I would like to turn it over to Analysis CFO, Randall McRae. Randall?
You're reading a preview of the NSCI Q2 2024 earnings call.
Free account.
